Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Belgian Researchers Collaborate on Reproductive Genetics

This article has been updated to reflect that the PGT analysis will not use cell-free DNA.

NEW YORK (GenomeWeb) – Agilent Technologies announced today an extension of a collaboration focused on reproductive genetics. 

Agilent and the Centre for Human Genetics of the University of Leuven and University Hospital of Leuven will investigate new solutions for preimplantation genetic testing, which Agilent said could allow laboratories to use a single sequencing workflow for preimplantation genetic analysis for single gene disorders and translocation carriers. The technology would also allow such an analysis for preimplantation genetic screening of chromosomal abnormalities on the same embryo biopsy. 

According to Agilent, a commercial solution for PGT analysis may be available this year. A more comprehensive evaluation of the clinical use of the PGT solution would follow to discriminate between mitotic and meiotic aneuploidies, and to detect triploidy and uniparental isodisomy in embryo biopsies. 

Current PGS methods are unable to detect such chromosomal abnormalities, Agilent said, adding the goal is to provide tools to the in vitro fertilization community to "reduce the number of IVF cycles and time that are needed to achieve a healthy live birth." 

Joris Vermeesch, chair of the Centre for Human Genetics, will coordinate the collaboration. 

A grant from Flemish government in Belgium also supports the PGT development efforts. Further financial and other terms of the deal were not disclosed. 

The partners had an earlier collaboration that preceded the commercial launch of Agilent's OneSight software platform for visualizing and investigating chromosomal and subchromosomal aneuploidies in cell-free DNA sequencing data.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.